{"id":"bucloxic-acid","rwe":[],"tags":[{"label":"bucloxic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Neuromuscular Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bucloxonic acid","offLabel":[],"synonyms":["bucloxic acid","bucloxonic acid"],"timeline":[],"brandName":"Bucloxonic Acid","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bucloxic acid","explanation":"Imagine your body's cells have locks on them, and Bucloxonic Acid is a key that fits into one of those locks. When it binds, it can either turn the lock open or closed, depending on the specific target it's interacting with. This can affect how cells behave and communicate with each other, potentially leading to changes in various bodily functions.","oneSentence":"Bucloxonic Acid is thought to work by modulating a specific molecular target, although the exact mechanism is currently unknown.","technicalDetail":"Bucloxonic Acid is a small molecule that likely interacts with a specific protein or receptor, altering its activity and downstream signaling pathways. The precise molecular details of this interaction are currently unknown, but it is thought to involve a reversible binding event that modulates the target's function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/417","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUCLOXIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:03:36.432334","biosimilars":[],"competitors":[],"genericName":"bucloxic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"KV89R7ELF8","CHEBI":"CHEBI:135236","INN_ID":"3251","UMLSCUI":"C0054197","ChEMBL_ID":"CHEMBL1697824","PUBCHEM_CID":"93159","MESH_SUPPLEMENTAL_RECORD_UI":"C100223"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":11,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bucloxonic Acid (BUCLOXIC ACID) is a small molecule drug in the bucloxic acid class, originally developed by an unknown entity and currently owned by an unknown entity. Its target and exact mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of Bucloxonic Acid is unclear, with unknown patent status and generic manufacturers. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to determine the potential therapeutic applications and risks associated with this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}